Biomerica Statistics Share Statistics Biomerica has 2.55M
shares outstanding. The number of shares has increased by 4.23%
in one year.
Shares Outstanding 2.55M Shares Change (YoY) 4.23% Shares Change (QoQ) 4.23% Owned by Institutions (%) 0.69% Shares Floating 2.3M Failed to Deliver (FTD) Shares 1,329 FTD / Avg. Volume 2.6%
Short Selling Information The latest short interest is 67.81K, so 2.66% of the outstanding
shares have been sold short.
Short Interest 67.81K Short % of Shares Out 2.66% Short % of Float 2.83% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -13.06 and the forward
PE ratio is null.
Biomerica's PEG ratio is
0.47.
PE Ratio -13.06 Forward PE n/a PS Ratio 14.41 Forward PS n/a PB Ratio 11.84 P/FCF Ratio -14.25 PEG Ratio 0.47
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Biomerica.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.51,
with a Debt / Equity ratio of 0.12.
Current Ratio 3.51 Quick Ratio 2.43 Debt / Equity 0.12 Debt / EBITDA -0.13 Debt / FCF -0.14 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $84.61K Profits Per Employee $-93.41K Employee Count 64 Asset Turnover 0.59 Inventory Turnover 2.02
Taxes Income Tax 42K Effective Tax Rate -0.71%
Stock Price Statistics The stock price has increased by 21.37% in the
last 52 weeks. The beta is 0.26, so Biomerica's
price volatility has been higher than the market average.
Beta 0.26 52-Week Price Change 21.37% 50-Day Moving Average 3.3 200-Day Moving Average 3.71 Relative Strength Index (RSI) 42.8 Average Volume (20 Days) 51,032
Income Statement In the last 12 months, Biomerica had revenue of 5.42M
and earned -5.98M
in profits. Earnings per share was -0.36.
Revenue 5.42M Gross Profit 611K Operating Income -6.37M Net Income -5.98M EBITDA -5.99M EBIT -6.37M Earnings Per Share (EPS) -0.36
Full Income Statement Balance Sheet The company has 4.17M in cash and 785K in
debt, giving a net cash position of 3.38M.
Cash & Cash Equivalents 4.17M Total Debt 785K Net Cash 3.38M Retained Earnings -48.2M Total Assets 7.38M Working Capital 4.55M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -5.36M
and capital expenditures -115K, giving a free cash flow of -5.48M.
Operating Cash Flow -5.36M Capital Expenditures -115K Free Cash Flow -5.48M FCF Per Share -0.33
Full Cash Flow Statement Margins Gross margin is 11.28%, with operating and profit margins of -117.58% and -110.4%.
Gross Margin 11.28% Operating Margin -117.58% Pretax Margin -109.62% Profit Margin -110.4% EBITDA Margin -110.67% EBIT Margin -117.58% FCF Margin -101.13%
Dividends & Yields BMRA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for BMRA.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Apr 21, 2025. It was a
backward
split with a ratio of 1:8.
Last Split Date Apr 21, 2025 Split Type backward Split Ratio 1:8
Scores Altman Z-Score -7.93 Piotroski F-Score 3
